Lyons, France

Gabriel De Crozals



Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gabriel De Crozals: Innovator in Biomolecular Labeling

Introduction

Gabriel De Crozals is a notable inventor based in Lyons, France. He has made significant contributions to the field of biomolecular labeling, holding a total of 2 patents. His work focuses on innovative methods and materials that enhance the labeling of biomolecules and oligonucleotides.

Latest Patents

De Crozals' latest patents include "Diaminophenothiazinium derivatives for labeling biomolecules, method and substrate for labeling oligonucleotides, and oligonucleotides obtained." This invention relates to diaminophenothiazinium derivatives of a specific formula, which are utilized in the labeling of oligonucleotides. The methods described allow for the effective labeling of these biomolecules, enhancing their utility in various applications. Another significant patent is "Material for supported synthesis and method for growing oligonucleotides or peptides." This invention involves a porous support with functionalized nanoparticles that are covalently bonded, facilitating the growth of oligonucleotides or peptides on the support material.

Career Highlights

Throughout his career, Gabriel De Crozals has worked with esteemed institutions such as Université Claude Bernard Lyon I and the Centre National de la Recherche Scientifique. His research has contributed to advancements in the field of molecular biology and biochemistry.

Collaborations

De Crozals has collaborated with notable colleagues, including Carole Chaix and Carole Farre. These partnerships have further enriched his research and innovations in biomolecular labeling.

Conclusion

Gabriel De Crozals is a prominent figure in the realm of biomolecular innovations. His patents and research continue to influence the field, showcasing his commitment to advancing scientific knowledge and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…